Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis ...
FDA Recall #D-0249-2026 — Class II — December 18, 2025
Product Description
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Reason for Recall
Presence of particulate matter - Glass like particles.
Recalling Firm
Imprimis NJOF, LLC — Ledgewood, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
778 boxes of 15,540 pre-filled syringes
Distribution
U.S Nationwide
Code Information
Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated